
TILs’ Tomorrow Bringing More Cancers Under Immune Control
Tumor-infiltrating lymphocytes (TILs) are a grouping of mostly T cells that enter tumors and elicit an initial immune response. But as Jason Bock, PhD, co-founder and CEO of CTMC, explains, “These cells have been fighting against the tumor, but the balance …